Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Xilio Therapeutics, Inc. | 136,500 | reported | 16 Aug 2023 | tx 6+535,058 |
| Syndax Pharmaceuticals Inc | 103,000 | reported | 04 Feb 2026 | tx 7+138,000 |
| ACTUATE THERAPEUTICS, INC. | 15,000 | reported | 21 May 2026 | tx 1+15,000 |
| Mersana Therapeutics, Inc. | 0 | reported | 06 Jan 2026 | tx 44+3,273,154−360,185 |
| TESARO, Inc. | 0 | reported | 22 Jan 2019 | tx 46+234,364−234,364 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 May 2026 | GRANT_AWARD | ACTUATE THERAPEUTICS, INC. | 15,000 | 0.00 USD | deriv |
| 04 Feb 2026 | GRANT_AWARD | Syndax Pharmaceuticals Inc | 24,000 | 0.00 USD | |
| 06 Jan 2026 | TENDER | Mersana Therapeutics, Inc. | 9,573 | — | |
| 06 Jan 2026 | OTHER | Mersana Therapeutics, Inc. | 497 | — | deriv |
| 06 Jan 2026 | OTHER | Mersana Therapeutics, Inc. | 7,467 | — | deriv |
| 06 Jan 2026 | OTHER | Mersana Therapeutics, Inc. | 13,340 | — | deriv |
| 06 Jan 2026 | OTHER | Mersana Therapeutics, Inc. | 1,328 | — | deriv |
| 06 Jan 2026 | OTHER | Mersana Therapeutics, Inc. | 7,256 | — | deriv |
| 06 Jan 2026 | OTHER | Mersana Therapeutics, Inc. | 364 | — | deriv |
| 06 Jan 2026 | OTHER | Mersana Therapeutics, Inc. | 27,878 | — | deriv |
| 06 Jan 2026 | OTHER | Mersana Therapeutics, Inc. | 12,121 | — | deriv |
| 06 Jan 2026 | OTHER | Mersana Therapeutics, Inc. | 179 | — | deriv |
| 06 Jan 2026 | OTHER | Mersana Therapeutics, Inc. | 734 | — | deriv |
| 06 Jan 2026 | OTHER | Mersana Therapeutics, Inc. | 135 | — | deriv |
| 06 Jan 2026 | OTHER | Mersana Therapeutics, Inc. | 1,800 | — | deriv |
| 06 Jan 2026 | OTHER | Mersana Therapeutics, Inc. | 407 | — | deriv |
| 06 Jan 2026 | OTHER | Mersana Therapeutics, Inc. | 1,002 | — | deriv |
| 06 Jan 2026 | OTHER | Mersana Therapeutics, Inc. | 99 | — | deriv |
| 06 Jan 2026 | OTHER | Mersana Therapeutics, Inc. | 1,923 | — | deriv |
| 06 Jan 2026 | OTHER | Mersana Therapeutics, Inc. | 5,938 | — | deriv |
| 06 Jan 2026 | OTHER | Mersana Therapeutics, Inc. | 26,713 | — | deriv |
| 12 Sept 2025 | SALE | Mersana Therapeutics, Inc. | 2,012 | 7.31 USD | |
| 11 Sept 2025 | EXERCISE | Mersana Therapeutics, Inc. | 6,670 | 0.00 USD | |
| 11 Sept 2025 | EXERCISE | Mersana Therapeutics, Inc. | 6,670 | 0.00 USD | deriv |
| 19 May 2025 | PURCHASE | Syndax Pharmaceuticals Inc | 5,000 | 8.99 USD |